Terms: = Pancreatic cancer AND EPS15, AF-1P, 2060, ENSG00000085832, P42566, MLLT5, AF1P
15 results:
1. Duodenal neuroendocrine neoplasms on enhanced CT: establishing a diagnostic model with duodenal gastrointestinal stromal tumors in the non-ampullary area and analyzing the value of predicting prognosis.
Feng N; Chen HY; Lu YF; Pan Y; Yu JN; Wang XB; Deng XY; Yu RS
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15143-15157. PubMed ID: 37634206
[TBL] [Abstract] [Full Text] [Related]
2. Upregulation of CSNK1A1 induced by ITGB5 confers to hepatocellular carcinoma resistance to sorafenib in vivo by disrupting the eps15/EGFR complex.
Gu L; Jin X; Liang H; Yang C; Zhang Y
Pharmacol Res; 2023 Jun; 192():106789. PubMed ID: 37149115
[TBL] [Abstract] [Full Text] [Related]
3. Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options.
Zhang CY; Liu S; Yang M
World J Gastroenterol; 2022 Dec; 28(48):6827-6845. PubMed ID: 36632312
[TBL] [Abstract] [Full Text] [Related]
4. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study.
COVIDSurg Collaborative
Lancet Oncol; 2021 Nov; 22(11):1507-1517. PubMed ID: 34624250
[TBL] [Abstract] [Full Text] [Related]
5. Serotonin immunoreactive pancreatic neuroendocrine neoplasm associated with main pancreatic duct dilation: a recognizable entity with excellent long-term outcome.
Dioguardi Burgio M; Cros J; Panvini N; Depoilly T; Couvelard A; Ruszniewski P; de Mestier L; Hentic O; Sauvanet A; Dokmak S; Faccinetto A; Ronot M; Vilgrain V
Eur Radiol; 2021 Nov; 31(11):8671-8681. PubMed ID: 33977308
[TBL] [Abstract] [Full Text] [Related]
6. [Stereotactic ablative body radiotherapy (SABRT) for locally advanced pancreatic cancer. Case report and review of literature].
Földi G; Zongor Z; Polgár C; Stelczer G; Madaras B; Andi J; Lövey J
Magy Onkol; 2017 Dec; 61(4):387-392. PubMed ID: 29257159
[TBL] [Abstract] [Full Text] [Related]
7. Marital status is an independent prognostic factor for pancreatic neuroendocrine tumors patients: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
Zhou H; Zhang Y; Song Y; Tan W; Qiu Z; Li S; Chen Q; Gao S
Clin Res Hepatol Gastroenterol; 2017 Sep; 41(4):476-486. PubMed ID: 28416359
[TBL] [Abstract] [Full Text] [Related]
8. Irinotecan plus cisplatin followed by octreotide long-acting release maintenance treatment in advanced gastroenteropancreatic neuroendocrine carcinoma: IPO-NEC study.
Li J; Lu M; Lu Z; Li Z; Liu Y; Yang L; Li J; Zhang X; Zhou J; Wang X; Gong J; Gao J; Li Y; Shen L
Oncotarget; 2017 Apr; 8(15):25669-25678. PubMed ID: 27788498
[TBL] [Abstract] [Full Text] [Related]
9. [Safety and tolerability of GLP-1 receptor agonists].
Soldevila B; Puig-Domingo M
Med Clin (Barc); 2014; 143 Suppl 2():35-40. PubMed ID: 25326842
[TBL] [Abstract] [Full Text] [Related]
10. [Expression of mitogen activated protein kinase phosphatase-1 in pancreatic cancer].
Guo JC; Shen SJ; Zhao YP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Dec; 35(6):645-8. PubMed ID: 24382243
[TBL] [Abstract] [Full Text] [Related]
11. [Endocrine tumors of the pancreas (EPTs) in multiple endocrine neoplasia (MEN1): up-date on prognostic factors, diagnostic procedures and treatment].
Libé R; Chanson P
Ann Endocrinol (Paris); 2007 Jun; 68 Suppl 1():1-8. PubMed ID: 17961653
[TBL] [Abstract] [Full Text] [Related]
12. Glutathione-s-transferase M1 and T1 polymorphisms and associations with type 1 diabetes age-at-onset.
Bekris LM; Shephard C; Peterson M; Hoehna J; Van Yserloo B; Rutledge E; Farin F; Kavanagh TJ; Lernmark A
Autoimmunity; 2005 Dec; 38(8):567-75. PubMed ID: 16390810
[TBL] [Abstract] [Full Text] [Related]
13. Effect of gastrin-releasing peptide on the pancreatic tumor cell line (Capan).
Avis I; Jett M; Kasprzyk PG; Cuttitta F; Treston AM; Maneckjee R; Mulshine JL
Mol Carcinog; 1993; 8(4):214-20. PubMed ID: 8280369
[TBL] [Abstract] [Full Text] [Related]
14. Location, incidence, and malignant potential of duodenal gastrinomas.
Thom AK; Norton JA; Axiotis CA; Jensen RT
Surgery; 1991 Dec; 110(6):1086-91; discussion 1091-3. PubMed ID: 1745977
[TBL] [Abstract] [Full Text] [Related]
15. Characterization of inactive renin ("prorenin") from renin-secreting tumors of nonrenal origin. Similarity to inactive renin from kidney and normal plasma.
Atlas SA; Hesson TE; Sealey JE; Dharmgrongartama B; Laragh JH; Ruddy MC; Aurell M
J Clin Invest; 1984 Feb; 73(2):437-47. PubMed ID: 6365974
[TBL] [Abstract] [Full Text] [Related]
